Triple
T2190768
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Janssen COVID-19 Vaccine |
E49854
|
entity |
| Predicate | efficacyAgainstSymptomaticCOVID19 |
P37231
|
FINISHED |
| Object | approximately 66 percent in global phase 3 trial |
—
|
LITERAL FINISHED |
Provenance (4 batches)
| Stage | Batch ID | Job type | Status |
|---|---|---|---|
| creating | batch_69a88aaba3c48190b351cab9b26989ff |
elicitation | completed |
| NER | batch_69abbf9e99f08190892d34485c8f2f25 |
ner | completed |
| PD | batch_69abbda32d1881909d1fd83a751fb21c |
pd | completed |
| PDg | batch_69abbf9c77fc8190a323bcaf644fb2c5 |
pdg | completed |
Created at: March 4, 2026, 7:46 p.m.